Factors that contribute to treatment decisions in acute myeloid leukemia

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Christoph Röllig, MD, from the University Hospital Carl Gustav Carus, Dresden, Germany, explains the different therapeutic needs of patients with acute myeloid leukemia, which is recognised as a clinically heterogeneous disease.

Share this video  
25th February 2016